Knowledge · Labs and diagnosticshs-CRP: C-reactive protein structure, local inflammation, and vascular risk
Knowledge · GeneralInterleukin-6: receptor context, trans-signaling, and the limits of selective therapyHow IL-6 receptors, ADAM10/17 proteolysis, and JAK–STAT3 shape tissue responses, what olamkicept trials found, and why selectivity has limits.October 9, 2026